Skip to main content

Peer Review reports

From: MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma

Original Submission
5 Nov 2020 Submitted Original manuscript
17 Dec 2020 Reviewed Reviewer Report
27 Jan 2021 Reviewed Reviewer Report
1 Mar 2021 Author responded Author comments - Yaoyao Gu
Resubmission - Version 2
1 Mar 2021 Submitted Manuscript version 2
20 Mar 2021 Author responded Author comments - Yaoyao Gu
Resubmission - Version 3
20 Mar 2021 Submitted Manuscript version 3
31 Mar 2021 Reviewed Reviewer Report
19 Apr 2021 Author responded Author comments - Yaoyao Gu
Resubmission - Version 4
19 Apr 2021 Submitted Manuscript version 4
28 Apr 2021 Reviewed Reviewer Report
29 Apr 2021 Author responded Author comments - Yaoyao Gu
Resubmission - Version 5
29 Apr 2021 Submitted Manuscript version 5
5 May 2021 Reviewed Reviewer Report
7 May 2021 Author responded Author comments - Yaoyao Gu
Resubmission - Version 6
7 May 2021 Submitted Manuscript version 6
Publishing
11 May 2021 Editorially accepted
7 Jul 2021 Article published 10.1186/s12885-021-08344-z

You can find further information about peer review here.

Back to article page